Sign In
Buy SGEN
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Pfizer in talks to acquire biotech firm Seagen for $30 billion: Report
09:47am, Monday, 27'th Feb 2023
Yahoo Finance Live's Julie Hyman reports that Pfizer is looking to acquire biotech firm Seagen in a $30 billion takeover deal.
Seagen (SGEN) Likely to be Acquired by Pfizer Claims WSJ
09:47am, Monday, 27'th Feb 2023
Seagen (SGEN) may be acquired by the large-cap pharma company Pfizer at a valuation of more than $30 billion, according to a Wall Street Journal article. Seagen's stock is up 17% in pre-market hours i
Seagen stock jumps on Pfizer takeover talk
09:42am, Monday, 27'th Feb 2023
Pfizer Inc (NYSE:PFE) is reportedly in talks to buy Seagen Inc (Seattle Genetics, Inc. (NASDAQ:SGEN)), a cancer drug maker that was last year tied to a potential takeover by Merk before negotiations b
Seagen's stock surges 15% after a report that Pfizer is in talks to buy the cancer-focused biotech
08:50am, Monday, 27'th Feb 2023
Pfizer is in early talks to acquire cancer drugmaker Seagen in a potentially multibillion-dollar deal, The Wall Street Journal reported Monday.
Seagen to Present at the Cowen 43rd Annual Health Care Conference
08:00am, Monday, 27'th Feb 2023
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq:SGEN) today announced that management will participate in a fireside chat at the Cowen 43rd Annual Health Care Conference on Monday, March 6, 2023
Seagen's stock soars on reported Pfizer buyout interest; Union Pacific shares rally after CEO ouster
07:54am, Monday, 27'th Feb 2023
Here are some of the most active stocks in the premarket on Monday. U.S. stock futures ES00, +0.50% were pointing to an advance after the worst week for the S&P 500 SPX, -1.05% since the period that e
Pfizer in Talks to Buy Seagen for $30 Billion or More
04:17am, Monday, 27'th Feb 2023
The deal would strengthen Pfizer's lineup of cancer treatments, The Wall Street Journal reports.
Pfizer in talks to buy Seagen for likely for more than $30 bln - WSJ
10:35pm, Sunday, 26'th Feb 2023
Pfizer Inc is in early talks to acquire drugmaker Seagen Inc , the Wall Street Journal reported late on Sunday, citing people familiar with the matter.
Pfizer in Early-Stage Talks to Acquire Seagen
09:56pm, Sunday, 26'th Feb 2023
Pfizer Inc. is in talks to acquire biotech Seagen Inc, according to people familiar with the matter, the latest potential deal for a big drug company aimed at adding a promising class of targeted canc
Why Seagen Stock Is Soaring Today
11:50am, Thursday, 16'th Feb 2023
Investors and analysts liked what they heard in the company's Q4 update.
Seagen's (SGEN) Q4 Earnings & Sales Beat Estimates, Stock Up
11:19am, Thursday, 16'th Feb 2023
Seagen (SGEN) reports better-than-expected results in the fourth quarter of 2022, beating both earnings and sales estimates. Stock up in the after-market hours in response to the news.
Seagen Inc. (SGEN) Q4 2022 Earnings Call Transcript
09:17pm, Wednesday, 15'th Feb 2023
Seagen Inc. (NASDAQ:SGEN ) Q4 2022 Results Conference Call February 15, 2023 4:30 PM ET Company Participants Doug Maffei - VP, IR David Epstein - CEO Chip Romp - EVP, Commercial U.S. Todd Simpson - CF
Seattle Genetics (SGEN) Reports Q4 Loss, Tops Revenue Estimates
06:49pm, Wednesday, 15'th Feb 2023
Seattle Genetics (SGEN) delivered earnings and revenue surprises of 21.57% and 9.35%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
4 Biotech Stocks Set to Outpace Q4 Earnings Estimates
03:48pm, Friday, 03'rd Feb 2023
Let us look at some biotech stocks, ALLO, EDIT, NTLA and SGEN that are poised to beat on fourth-quarter earnings.
Seagen's (SGEN) Tukysa Gets Accelerated FDA Nod for New Indication
09:02am, Friday, 20'th Jan 2023
The FDA grants accelerated approval to Seagen's (SGEN) Tukysa in combination with trastuzumab for previously treated HER2-positive metastatic colorectal cancer.
